<html>
<head>PUBMED IDs for IGHD3-3</head>
<body bgcolor='#C5F0F2'><h1>IGHD3-3</h1><a href='https://pubmed.ncbi.nlm.nih.gov/17675554/'>Nonstochastic pairing of immunoglobulin heavy and light chains expressed by chronic lymphocytic leukemia B cells is predicated on the heavy chain CDR3.</a> August 7  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/18064298/'>Immunoglobulin diversity gene usage predicts unfavorable outcome in a subset of chronic lymphocytic leukemia patients.</a> December 8  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/20064162/'>IGHD3-3 fails to behave as unfavourable prognostic marker in chronic lymphocytic leukaemia.</a> July 2  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/21968789/'>Partial versus productive immunoglobulin heavy locus rearrangements in chronic lymphocytic leukemia: implications for B-cell receptor stereotypy.</a> June 2  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/23840319/'>IGHV1-69-encoded antibodies expressed in chronic lymphocytic leukemia react with malondialdehyde-acetaldehyde adduct, an immunodominant oxidation-specific epitope.</a> February 6  2013<br></body></html>
